best performing nasdaq stocks 20 dec 2010 to 30 dec 2012

GT Biopharma (GTBP) had the highest return between December 20, 2010 and December 30, 2012 by a US stock in the Nasdaq Composite (IXIC), returning 585,518,836.5%.

ASSET DATE % RETURN
GT Biopharma (GTBP)
12/20/2010 - 12/30/2012
585,518,836.54%
Xpel (XPEL)
12/20/2010 - 12/30/2012
1,371.77%
Nova Lifestyle I (NVFY)
12/20/2010 - 12/30/2012
1,266.67%
Kazia Therapeutics Ltd ADR (KZIA)
12/20/2010 - 12/30/2012
1,189.17%
Natural Health Trend (NHTC)
12/20/2010 - 12/30/2012
1,021.97%
Heritage Global (HGBL)
12/20/2010 - 12/30/2012
816.67%
Barfresh Food (BRFH)
12/20/2010 - 12/30/2012
786%
Patrick Industries (PATK)
12/20/2010 - 12/30/2012
745.49%
Where Food Comes From (WFCF)
12/20/2010 - 12/30/2012
733.35%
Astrana Health (ASTH)
12/20/2010 - 12/30/2012
560%
Intelligent Protection Management (IPM)
12/20/2010 - 12/30/2012
522.22%
BioLife Solutions (BLFS)
12/20/2010 - 12/30/2012
518.18%
Mawson Infrastructure (MIGI)
12/20/2010 - 12/30/2012
500%
Consumer Portfolio Services (CPSS)
12/20/2010 - 12/30/2012
496.63%
ACADIA Pharmaceuticals (ACAD)
12/20/2010 - 12/30/2012
478.21%
Precision Optics Corporation, Inc Common stock (POCI)
12/20/2010 - 12/30/2012
466.67%
Lifevantage (LFVN)
12/20/2010 - 12/30/2012
462.16%
Expedia (EXPE)
12/20/2010 - 12/30/2012
454.13%
Security National Financial (SNFCA)
12/20/2010 - 12/30/2012
437.61%
Aemetis (AMTX)
12/20/2010 - 12/30/2012
421.43%
Usio (USIO)
12/20/2010 - 12/30/2012
409.41%
Maywood Acquisition Corp Class A Ordinary Shares (MAYA)
12/20/2010 - 12/30/2012
407.46%
Regeneron Pharmaceuticals (REGN)
12/20/2010 - 12/30/2012
405.93%
OLB (OLB)
12/20/2010 - 12/30/2012
326.83%
Cardiff Oncology (CRDF)
12/20/2010 - 12/30/2012
326.54%